Literature DB >> 16369003

Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection.

Christopher K Cote1, Nico Van Rooijen, Susan L Welkos.   

Abstract

The development of new approaches to combat anthrax requires that the pathogenesis and host response to Bacillus anthracis spores be better understood. We investigated the roles that macrophages and neutrophils play in the progression of infection by B. anthracis in a mouse model. Mice were treated with a macrophage depletion agent (liposome-encapsulated clodronate) or with a neutrophil depletion agent (cyclophosphamide or the rat anti-mouse granulocyte monoclonal antibody RB6-8C5), and the animals were then infected intraperitoneally or by aerosol challenge with fully virulent, ungerminated B. anthracis strain Ames spores. The macrophage-depleted mice were significantly more susceptible to the ensuing infection than the saline-pretreated mice, whereas the differences observed between the neutropenic mice and the saline-pretreated controls were generally not significant. We also found that augmenting peritoneal neutrophil populations before spore challenge did not increase resistance of the mice to infection. In addition, the bacterial load in macrophage-depleted mice was significantly greater and appeared significantly sooner than that observed with the saline-pretreated mice. However, the bacterial load in the neutropenic mice was comparable to that of the saline-pretreated mice. These data suggest that, in our model, neutrophils play a relatively minor role in the early host response to spores, whereas macrophages play a more dominant role in early host defenses against infection by B. anthracis spores.

Entities:  

Mesh:

Year:  2006        PMID: 16369003      PMCID: PMC1346637          DOI: 10.1128/IAI.74.1.469-480.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  65 in total

Review 1.  How do neutrophils and pathogens interact?

Authors:  Anne Mayer-Scholl; Petra Averhoff; Arturo Zychlinsky
Journal:  Curr Opin Microbiol       Date:  2004-02       Impact factor: 7.934

2.  Dual role for macrophages in vivo in pathogenesis and control of murine Salmonella enterica var. Typhimurium infections.

Authors:  O L Wijburg; C P Simmons; N van Rooijen; R A Strugnell
Journal:  Eur J Immunol       Date:  2000-03       Impact factor: 5.532

3.  The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.

Authors:  S Welkos; S Little; A Friedlander; D Fritz; P Fellows
Journal:  Microbiology       Date:  2001-06       Impact factor: 2.777

4.  Anthrax toxin induces hemolysis: an indirect effect through polymorphonuclear cells.

Authors:  Aiguo G Wu; Darya Alibek; Yue Lydia Li; Chris Bradburne; Charles L Bailey; Kenneth Alibek
Journal:  J Infect Dis       Date:  2003-09-30       Impact factor: 5.226

5.  Macrophages in spleen and liver direct the migration pattern of rat neutrophils during inflammation.

Authors:  E Knudsen; H B Benestad; T Seierstad; P O Iversen
Journal:  Eur J Haematol       Date:  2004-08       Impact factor: 2.997

6.  Mouse susceptibility to anthrax lethal toxin is influenced by genetic factors in addition to those controlling macrophage sensitivity.

Authors:  Mahtab Moayeri; Nathaniel W Martinez; Jason Wiggins; Howard A Young; Stephen H Leppla
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

7.  Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility.

Authors:  C Rick Lyons; Julie Lovchik; Julie Hutt; Mary F Lipscomb; Eugenia Wang; Sara Heninger; Lucy Berliba; Kristin Garrison
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

Review 8.  Bacillus species proteins involved in spore formation and degradation: from identification in the genome, to sequence analysis, and determination of function and structure.

Authors:  Mark J Jedrzejas; Wendy J M Huang
Journal:  Crit Rev Biochem Mol Biol       Date:  2003       Impact factor: 8.250

9.  Systemic cytokine response in murine anthrax.

Authors:  Serguei G Popov; Taissia G Popova; Edith Grene; Francis Klotz; Jennifer Cardwell; Chris Bradburne; Yusuf Jama; Matthew Maland; Jay Wells; Aysegul Nalca; Tom Voss; Charles Bailey; Ken Alibek
Journal:  Cell Microbiol       Date:  2004-03       Impact factor: 3.715

10.  A microtiter fluorometric assay to detect the germination of Bacillus anthracis spores and the germination inhibitory effects of antibodies.

Authors:  Susan L Welkos; Christopher K Cote; Kelly M Rea; Paul H Gibbs
Journal:  J Microbiol Methods       Date:  2004-02       Impact factor: 2.363

View more
  74 in total

1.  Anthrax toxin delivers a one-two punch.

Authors:  Kenneth A Bradley; Steven M LeVine
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

2.  Fully virulent Bacillus anthracis does not require the immunodominant protein BclA for pathogenesis.

Authors:  J Bozue; C K Cote; K L Moody; S L Welkos
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

3.  What is the relevance of lung epithelial cells during the dissemination of spores in inhalational anthrax?

Authors:  Jean-Nicolas Tournier; Aurélie Cleret; Anne Quesnel-Hellmann
Journal:  Infect Immun       Date:  2009-01       Impact factor: 3.441

4.  Gene expression profiling of primary human type I alveolar epithelial cells exposed to Bacillus anthracis spores reveals induction of neutrophil and monocyte chemokines.

Authors:  J Leland Booth; Elizabeth S Duggan; Vineet I Patel; Wenxin Wu; Dennis M Burian; David C Hutchings; Vicky L White; K Mark Coggeshall; Mikhail G Dozmorov; Jordan P Metcalf
Journal:  Microb Pathog       Date:  2018-04-25       Impact factor: 3.738

5.  Bacillus anthracis has two independent bottlenecks that are dependent on the portal of entry in an intranasal model of inhalational infection.

Authors:  David E Lowe; Stephen M C Ernst; Christine Zito; Jason Ya; Ian J Glomski
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

6.  Poly-gamma-glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracis.

Authors:  Angelo Scorpio; Donald J Chabot; William A Day; David K O'brien; Nicholas J Vietri; Yoshifumi Itoh; Mansour Mohamadzadeh; Arthur M Friedlander
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

7.  Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model.

Authors:  Crystal L Loving; Taruna Khurana; Manuel Osorio; Gloria M Lee; Vanessa K Kelly; Scott Stibitz; Tod J Merkel
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

8.  Four superoxide dismutases contribute to Bacillus anthracis virulence and provide spores with redundant protection from oxidative stress.

Authors:  Robert J Cybulski; Patrick Sanz; Farhang Alem; Scott Stibitz; Robert L Bull; Alison D O'Brien
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

9.  A genetically enhanced anaerobic bacterium for oncopathic therapy of pancreatic cancer.

Authors:  Zhiyu Li; John Fallon; John Mandeli; James Wetmur; Savio L C Woo
Journal:  J Natl Cancer Inst       Date:  2008-09-23       Impact factor: 13.506

10.  Discriminating virulence mechanisms among Bacillus anthracis strains by using a murine subcutaneous infection model.

Authors:  Hitendra S Chand; Melissa Drysdale; Julie Lovchik; Theresa M Koehler; Mary F Lipscomb; C Rick Lyons
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.